Integrating NORTHSTAR/COMPEL Into Clinical Practice: A Tumor Board Focused on Duration of Osimertinib Therapy

Faculty: Charu Aggarwal, MD, MPH and Zofia Piotrowska, MD, MHS
Disclosures

Supported by AstraZeneca, Lilly, OMNI Oncology, and The Personalized Medicine Foundation.

Panelists

Charu Aggarwal, MD, MPH

Physician Leader, Airways Malignancies Research Director
Precision Oncology Innovation, Penn Center for Cancer Care Innovation
Section Chief, Head & Neck and Thoracic Cancers, Hematology-Oncology
Leslye M. Heisler Professor for Lung Cancer Excellence
Penn Medicine

Zofia Piotrowska, MD, MHS

Associate Professor of Medicine, Harvard Medical School

Clinical Co-Director, MGB Thoracic Medical Oncology Program

Mass General Brigham Cancer Institute

Boston, Massachusetts

Discover more from OmniOncology.net

Subscribe now to keep reading and get access to the full archive.

Continue reading